commercialization strategy

Affirmed Pharma is a translational drug development company whose teams coordinate investigational, regulatory, intellectual property and commercialization strategies to move promising development-stage drugs through regulatory approval with new patents. It targets therapies in late-stage pre-clinical or early clinical development at research organizations, universities and university spin-out companies lacking commercialization experience, leveraging patent family development strategies with formulation and clinical research organizations.

clinical researchformulationintellectual property strategypatent family developmentregulatory strategy

Biomedical Commercialization LLC (BCL) is a medical device consulting firm led by founder Barry Michael, ScB, MBA. It provides project-based and fractional vice-presidential support focused on strategic planning, marketing, sales, and operations, and helps clients overcome development obstacles, navigate regulatory challenges, and transition products to market. It also offers speaking engagements and mentoring.

clinical documentation preparationgo-to-market strategymedical device consultingmentoringregulatory compliance support (FDA, CE, ISO)speaking engagementsstrategic-planning

Boost Innovation Group, LLC is a full-service innovation and technology commercialization consultancy, specializing in high-tech startups and university research. Since 2005, its network of commercialization strategists, marketers, startup and patent attorneys, and other innovation professionals has helped startups, inventors, and scientists bring new products and services to markets worldwide in more than 1,500 engagements. It supports the SBA's SBIR and STTR programs and is an approved voucher provider in the Department of Energy's Energywerx program.

fundraising strategygo-to-market strategygrant assessment and developmentMarket Analysispitch deck developmentpricing strategy

Concept to Market LLC is an advisory firm that helps life science innovators secure non-dilutive funding to bring pharmaceutical, biotech, and medical technologies to market without giving up equity. With over 25 years of experience and $3B+ in non-dilutive funding secured, it provides strategic, end-to-end support across government grants, public-sector contracts, and foundation-backed capital, from proposal development to post-award compliance and commercialization strategy.

compliancefunding strategyprogram managementproposal developmentregulatory strategy